We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OCFT
11976
CALL
DELISTED
OneConnect Financial Technology
OCFT
$39K ﹤0.01%
2,270
-310
-12% -$4.39K
QUAD icon
11977
CALL
Quad
QUAD
$513M
$39K ﹤0.01%
+14,300
New +$69.2K
RDHL
11978
CALL
Redhill Biopharma
RDHL
$3.65M
$39K ﹤0.01%
45
-17
-27% -$23.3K
AIFF
11979
Firefly Neuroscience
AIFF
$17.1M
$39K ﹤0.01%
+973
New +$93.9K
ALPP
11980
PUT
DELISTED
Alpine 4 Holdings Inc
ALPP
$39K ﹤0.01%
6,950
-3,988
-36% -$25.6K
TRHC
11981
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$39K ﹤0.01%
+15,200
New +$57K
ZYNE
11982
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$39K ﹤0.01%
34,000
+10,000
+42% +$12.7K
APTO
11983
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$39K ﹤0.01%
118
+18
+18% +$8.61K
SGTX
11984
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$39K ﹤0.01%
+3,603
New +$48.4K
ELVT
11985
CALL
DELISTED
Elevate Credit, Inc.
ELVT
$39K ﹤0.01%
+16,500
New +$44.8K
ONCS
11986
DELISTED
OncoSec Medical Incorporated
ONCS
$39K ﹤0.01%
2,397
+1,074
+81% +$20.6K
PME
11987
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$39K ﹤0.01%
43,509
+28,243
+185% +$24.6K
CKPT
11988
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$38K ﹤0.01%
3,690
-3,970
-52% -$52K
CUE icon
11989
PUT
Cue Biopharma
CUE
$233M
$38K ﹤0.01%
513
-70
-12% -$8.19K
FEMY icon
11990
Femasys
FEMY
$6.91M
$38K ﹤0.01%
+789
New +$26.7K
SEGG
11991
CALL
Sports Entertainment Gaming Global Corp
SEGG
$8.21M
$38K ﹤0.01%
24
-8
-25% -$20.9K
LITS
11992
Lite Strategy Inc
LITS
$30.2M
$38K ﹤0.01%
3,174
-50,405
-94% -$549K
OGI
11993
PUT
Organigram Holdings
OGI
$173M
$38K ﹤0.01%
10,300
-4,300
-29% -$21.9K
PMCB icon
11994
CALL
PharmaCyte Biotech
PMCB
$5.92M
$38K ﹤0.01%
16,800
-17,700
-51% -$38.7K
RDW icon
11995
PUT
Redwire
RDW
$3.39B
$38K ﹤0.01%
12,600
-22,500
-64% -$108K
SBET icon
11996
Sharplink Inc
SBET
$1.36B
$38K ﹤0.01%
+354
New +$43.2K
SIFY
11997
Sify Technologies
SIFY
$1.13B
$38K ﹤0.01%
3,263
+1,064
+48% +$15K
SOS
11998
SOS Limited
SOS
$15.9M
$38K ﹤0.01%
267
+26
+11% +$7.54K
SYPR icon
11999
Sypris Solutions
SYPR
$47.4M
$38K ﹤0.01%
16,444
-989
-6% -$2.23K
TDUP icon
12000
PUT
ThredUp
TDUP
$403M
$38K ﹤0.01%
15,100
-21,700
-59% -$117K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.